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players suffered acutely from "dehydration" after a game. The impression gained from this experience was that the main disability was a cumulative sodium chloride depletion. Three players suffered from severe giddiness, fatigue, nausea, and vomiting for up to 48 hours and would not have been fit to play again for several days. Attempts to use enteric-coated tablets of sodium chloride were singularly unsuccessful, and the use of compressed salt tablets had caused nausea and vomiting. By the time the same players returned to Mexico they were aware of the need for sodium chloride replacement. During the World Cup competition they were prepared to take as many Slow Sodium tablets as were considered necessary. One player took 200 mEq of Slow Sodium two hours before an intensive training session. In Mexico no player suffered from any clinical symptoms suggestive of either acute or chronic salt and water depletion.
Cramp is a common symptom reported in subjects suffering salt depletion. Collings, Shoudy, and Shaffer (1943) reported an incidence of 60% in his series and King and Barry (1962) The use of an acceptable oral sodium chloride preparation should also be of great value in some industrial workers. There are certain industries, such as the South African gold mines, in which the problem of adequate sodium chloride replacement has never been satisfactorily answered. We have also been told that sodium depletion is a great problem in the oil industry. Its use in other athletes who perform strenuous activities over a long period, such as tennis players and marathon runners, is obvious. The principle advantage of Slow Sodium for the healthy individual, apart from its freedom from side effects, is that not only can it correct a loss of sodium chloride after the loss has occurred but it can anticipate such a loss. Most of the absorption from the gut of the sodium chloride contained in Slow Sodium tablets is achieved at two and a half hours but continues for some time thereafter. Therefore, if a supply of Slow Sodium tablets is ingested at a suitable time before an acute sweat loss is about to take place it is possible for the loss to be at least partially replaced from the gut as it is occurring. In most prolonged industrial and athletic activity it is usually possible to have access to water from time to time. With a continuous absorption of sodium chloride from the Slow Sodium tablets in the intestine and the intermittent oral ingestion of water, the stultifying weariness and muscular weakness of extracellular fluid volume depletion need never occur.
Summary
The capacity of inpatients in a geriatric hospital to metabolize drugs was measured. were found to be 45% and 29% greater respectively in patients than in young controls. When women alone were considered the half-life of antipyrine was 78% longer in the elderly group. In a number of elderly individuals the rate of metabolism of these two drugs was found to be extremely slow. This decreased ability to metabolize drugs may contribute to the known high incidence of adverse drug reactions in the elderly.
Within the control group a significant sex difference in the rate of antipyrine metabolism was found, the mean half-life being 30% longer in the males. It is clear from these results that the age and sex of subjects must be taken into account in studies of human drug metabolism.
Introduction There is some evidence that, in adults, sensitivity to drugs may vary with age and sex (Bender, 1964; Hurwitz, 1969 ). An increased incidence of adverse drug reactions has been reported in older age groups, the frequency in those aged 70-79 years being seven times greater than that found in those aged 20-29 years (Hurwitz, 1969) . The finding of Kato et al. (1964) that hepatic drug metabolizing enzyme activity was decreased in aged rats suggests that impaired metabolism may be a factor contributing to the high incidence of adverse drug reactions in the elderly. Similarly, it is possible that the reported higher frequency of adverse drug reactions in women may be due to slower metabolism. Certainly, a sex difference in the rate of drug metabolism in rats is well documented (Conney, 1967 (Snedecor and Cochran, 1968) . between the groups was significant (P <0-01). The mean plasma phenylbutazone half-life was 104-6 ± 49-7 hours in the aged group (6 male, 13 female) and 81-2 ± 19-4 hours in the younger group (11 male, 7 female). With this drug, though the mean half-life in the older group seemed longer, the difference between the two groups was not significant. Extrapolation of the lines to zero time would indicate a small difference in apparent volume of distribution of antipyrine, but statistical analysis of the individual intercepts showed this not to be significant (P> 0 05, Student's t test). With phenylbutazone, however, there was a significant difference (P <0 01, t test) in the apparent volume of distribution in the two groups, the mean value in the elderly subjects being 21% greater.
In the younger subjects (Fig. 4) higher at the P <0 001 level (t test) than in females (10-3 ± 2-1 hours). From the composite regression lines (Fig. 3 C) the apparent volume of distribution of antipyrine was found to be significantly lower in the female group.
Discussion
Though the possibility has long been recognized of a reduced ability to metabolize drugs in the elderly, no formal comparisons of drug metabolizing capacity in the aged and young adults have been made. In the present study the plasma half-life values obtained with antipyrine (45% longer) and to a lesser extent with phenylbutazone (29% longer) indicate a decreased rate of drug metabolism in geriatric patients. This is in agreement with the earlier finding of Kato et al. (1964) from animal studies. The demonstration of a decreased rate of drug metabolism in elderly patients may in part account for the higher incidence of adverse drug reactions in older patients. The pronounced difference in apparent volume of distribution of phenylbutazone in the two groups is interesting (Fig. 3B) . The most likely explanation is a decreased absorption of the drug. However, a decrease in protein binding or an increase in extracellular fluid volume would also have to be considered. The latter is unlikely because the apparent volume of distribution of antipyrine (Fig. 3A) , which is known to be evenly distributed throughout total body water , indicates, if anything, a decrease in total body water in the elderly.
Though the mean half-life values with both drugs would suggest slower metabolism in the elderly, it is perhaps more important to note that within the elderly population (Figs. 1 and 2) there are a few individuals with apparently normal liver function whose ability to metabolize is well outside the normal range. It is conceivable that these would be the subjects most likely to develop drug side effects.
From the antipyrine results in the younger group there is apparently a sex difference in the rate of metabolism of this drug (Fig. 4) . The small number of subjects in which phenylbutazone was studied does not allow assessment of a possible sex difference with this agent. To date, a significant sex difference in drug metabolism has not been found, though the figures as reported by Vesell and Page (1968a, 1968b) for antipyrine and for phenylbutazone respectively would suggest a slightly lower rate of metabolism in males. Whittaker and Price Evans (1970) , however, found no sex difference in the rate of phenylbutazone metabolism in a large group of normal subjects. The observation of a sex difference in this but not in previous studies is interesting. Since drug metabolism is known to be under genetic control (Vesell and Page, 1969) and is influenced by drugs (Vesell and Page, 1969, O'Malley et al., 1970) and environmental factors (Fouts, 1971) , it is possible that a sex difference will be observed only where the population studied is relatively homogeneous.
The apparent volume of distribution of antipyrine (Fig. 3 C) was lower in the female group, a finding in agreement with Soberman et al. (1949) . A change in volume of distribution of such a freely diffusable drug would not be expected to account for the observed change in rate of metabolism.
From these observations it is obvious that the sex of subjects should be taken into account in studies of drug metabolism in humans. In the present study of drug metabolism in geriatric patients insufficient male subjects were obtained to allow a comparison with a younger male group. With the females, however, the antipyrine values in the elderly group (18-3 ± 7-1 hours, n = 15) were 78% higher than in the younger females (10-3 ± 2-1 hours, n = 27)-that is, the slower rate of metabolism is, in this case, more pronounced than when the whole elderly population was compared with the younger group.
Since, from these results, men would seem to be slower metabolizers of drugs than women, it might be expected that men would be more sensitive to drugs. In fact Hurwitz (1969) reported a higher incidence of adverse drug reactions in women No breakdown was given, however, of reactions due to drugs which are metabolized as distinct from those with drugs which are excreted unchanged.
